UL-16 binding protein 5 Antibodies

AND RAET1G ELISA kits, UL-16 binding protein 5 Proteins

Many biological assays use antibodies to detect UL-16 binding protein 5, such as Western Blot (WB), ELISA, Flow Cytometry, Immunocytochemistry (IHC). These antibodies can be polyclonal or monoclonal, and react with UL-16 binding protein 5 in Human, Mouse, Rat, and many other animal samples. Boster Bio use mainly mouse and rabbit to develop UL-16 binding protein 5 antibodies...

We validate the specificity of these antibodies to UL-16 binding protein 5 by testing them on tissues known to express RAET1G positively and negatively. Browse below to find the RAET1G antibody that suites your experiment. We have 1 of these antibodies and many publications and validation images.

If you cannot find antibodies that fit your needs, contact us for making custom antibodies. We have a full suite of custom antibody services covering from research to diagnostic and therapeutic applications.

Previous: Septin9 Next: RILPL1

RAET1G Infographic by Boster Bio

All RAET1G Products

Filter by Application:

Product

Figures

Specificity

Applications

Price

RAET1G Retinoic Acid Early Transcript 1G Human Recombinant Protein

Human

$250
Cat # PROTQ6H3X3
2ug, 10ug, 1mg

RAET1G Overview

Facts about UL-16 binding protein 5.

RAET1G 3D structure. Source: alphafold

UL-16 binding protein 5 (RAET1G)

Isoform 1: Binds and activates the KLRK1/NKG2D receptor, mediating natural killer cell cytotoxicity. .

Gene Information

Human
Gene Name:	RAET1G
Uniprot:	Q6H3X3
Entrez:	353091

Family

Belongs to:

MHC class I family

Alternative Names

RAET1G; retinoic acid early transcript 1G protein; retinoic acid early transcript 1G pseudogene; retinoic acid early transcript 1G; ULBP5; ULBP-5

Molecular Weight

Mass (kDA):
37.106 kDA

Genomic Context


Human

Location:	6q25.1
Sequence:	6; NC_000006.12 (149916878..149923133, complement)

Tissue Specificity

Isoform 1 is highly expressed in colon and in a number of tumor cell lines and highly restricted in normal tissues. Both isoforms are frequently expressed in cell lines derived from epithelial cancers, and in primary breast cancers.